Which liquid biopsy analytes have the highest potential for improved patient stratification in clinical trials within the next 5 years?

Vote below
95 votes
Cell-free DNA
47%
50 votes
Circulating tumor cells
25%
27 votes
Exosomes / extracellular vesicles
13%
10 votes
Cell-free RNA / miRNA
5%
20 votes
Multiple analytes
10%